Geneviève Inchauspé has over 20 years of experience in academia occupying different positions at the interface between basic and clinical research before joining the industry (Transgene). She has developed a strong expertise in vaccinology, immunotherapy, immunology and virology through the conduct of studies in various animal models, including non-human primates. She has been driving the specific development of therapeutic vaccine candidates from pre-clinical to clinical development for hepatitis B and C (Phase 1 and 2). Geneviève Inchauspé has over 20 years of experience in academia occupying different positions at the interface between basic and clinical research before joining the industry (Transgene). She has developed a strong expertise in vaccinology, immunotherapy, immunology and virology through the conduct of studies in various animal models, including non-human primates. She has been driving the specific development of therapeutic vaccine candidates from pre-clinical to clinical development for hepatitis B and C (Phase 1 and 2).

Vaccines, vaccination, veterinary sciences